Axsome Therapeutics Inc

NASDAQ:AXSM   3:59:58 PM EDT
48.59
-1.98 (-3.92%)
Products

Axsome Therapeutics - FDA Is Rescinding Co's Breakthrough Therapy Designation For Its Axs-12 Product Candidate

Published: 07/13/2021 21:10 GMT
Axsome Therapeutics Inc (AXSM) - Axsome Therapeutics - Notified by U.S. FDA That It is Rescinding Co’s Breakthrough Therapy Designation for Its Axs-12 Product Candidate.
Axsome - FDA Btd Rescindment Due to It Approving Additional Drug Product for Treatment of Cataplexy in Narcolepsy Subsequent to Granting Axs-12 Btd.
Axsome - Does Not Currently Anticipate Any Changes to Development Plans Or Associated Timelines for Axs-12 As a Result of FDA Btd Rescindment.